ARDX Chart
- 52-Week Range: $0.58 - $8.17
- Market Capitalization: $90.32M
- Short Percentage: 0%
- Target Price: $6.29
- Shares Outstanding: 144.60M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
ARDX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Ardelyx, Inc. (ARDX) CEO Mike Raab on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 5th
- Ardelyx: Speculative Biotech With Minimal Downside Risk For Time BeingSeeking Alpha | April 29th
- FDA Plans To Convene AdComm For Ardelyx's Tenapanor For CKD Patients On DialysisBenzinga | April 25th
- Ardelyx Announces FDA Plan to Convene Advisory Committee for XPHOZAH® (tenapanor)PRNewsWire | April 25th
- Hot Biotech Penny Stocks to Watch During the First Full Week of AprilPennyStocks | April 4th
Company Info
Website: https://www.ardelyx.com
Address: 400 Fifth Avenue, Waltham, MA, United States, 02451
Sector: Healthcare
Industry: Biotechnology
Full time employees: 86
Address: 400 Fifth Avenue, Waltham, MA, United States, 02451
Sector: Healthcare
Industry: Biotechnology
Full time employees: 86
$ARDX love cooking these little bears on here
$ARDX nice
$ARDX finally a pullback
$ARDX up we go
$ARDX now is the time to slap that ask!!!
$ARDX very normal lol sike
$ARDX I hate this company.
$ARDX buy SHARES
$ARDX Dumping started...
Get out while you can...
$ARDX who here can't stand the CEO?